Special

Cannabinoid Formulations for Specific Medical Diseases and Illnesses

Caleb Summeril
Written by Caleb Summeril

More research is seemingly being conducted daily into the benefits and potential healing properties of the over 90 different cannabinoids currently known to be in cannabis. The two most abundant cannabinoids present within the plant, THC and CBD, are well described, while a myriad of other cannabinoid formulations are now being examined and show promise for treating specific ailments.

On the cutting edge of this research is the potential benefits that cannabinoids show in treating cancer. [1] Studies have been looking into this since the mid-1970s, but current research points to the capacity for cannabinoids to inhibit the growth and development of certain tumor cells while triggering apoptotic cancer cell death. [2] Other research has shown that cannabinoids, in their natural phytochemical state as well as in synthetic forms, are effective in the treatment of many different types of cancers, including: glioma, colon, liver, pancreatic, breast, prostrate, lung and melanoma.

A number of new companies are exploring this exciting horizon of medical applications. InMed Pharmaceuticals is dedicated to developing technologically advanced cannabinoid-based medicines. Cannabics Pharmaceuticals is a company pursuing cancer-specific medicines through cannabinoid research and development. AXIM Biotech has developed a cannabinoid infused chewing gum and is a leader in pharmaceutical-grade cannabis extraction.

Specific diseases and illnesses and the cannabinoids that have been nominated as showing promise in treating the conditions(the reader is encouraged to seek out the specific scientific articles that have been published on these subjects, some of which are available on our website):

  • Cancer – CBC, CBD, CBDa, CBG, THC, THCa
  • HIV/AIDS – THC, THCa
  • Glaucoma – CBD, THC
  • Hypertension – CBD, THC
  • Fatigue – THC
  • Asthma – THC
  • Inflammation – CBC, CBD, CBDa, CBG, CBN, THC, THCa
  • Arthritis – CBC, CBD, CBDa, CBG, CBN, THC, THCa
  • Pain – CBC, CBD, CBN, THC, THCv
  • Insomnia – CBC, CBD, CBN, THC
  • Fibromyalgia – CBD, CBN, THC
  • Migraine – CBD, THC
  • Cramps – CBD, THC
  • Appetite Loss – THC
  • Anorexia – CBD, THC
  • Gastrointestinal disorders – CBD, THC
  • Nausea – CBD, THC
  • Diabetes – CBD, THCv
  • Crohn’s – CBD, THC, THCv
  • Anxiety – CBD, CBG
  • ADD/ADHAD – CBD, THC
  • Bipolar – CBD, THC, THCv
  • OCD – CBD, THC, THCv
  • PTSD – CBD, THC, THCv
  • Depression – CBC, CBD, CBN, THC
  • Tourette’s – THC
  • Epilepsy – CBD, CBN, THCa, THCv
  • Seizures – CBD, CBN, THCa, THCv
  • Multiple Sclerosis – CBD, CBN, THC, THCa
  • Alzheimer’s – CBC, CBD, CBG, THC, THCa
  • Parkinson’s – CBC, CBD, CBG, THC, THCa
  • Spasticity – CBD, CBG, CBN, THC, THCa
  • Osteoporosis – CBC, CBD, CBG, CBN, THCv
  • ALS – CBC, CBD, CBG, CBN, THC, THCv

References

1.    Sledzinski, Pawel et al. The current state and future perspectives of cannabinoids in cancer biology. Cancer Med. 2018, 7/3/767-775. Times cited = 2, Journal impact factor = 3.362

2.    Ladin, Daniel A. et al. Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents. Front Pharmacol. 2016, 7/361. Times cited = 3, Journal impact factor = 3.831

About the author

Caleb Summeril

Caleb Summeril

Leave a Comment